Oral chemoprevention with acetyl salicylic acid, vitamin D and calcium reduces the risk of tobacco carcinogen-induced bladder tumors in mice

Cancer Investigation

Volumn 31, Issue 7, 2013, Pages 490-493

  Pommergaard, H C ^a   Burcharth, J ^a   Rosenberg, J ^a   Raskov, H ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Diakonissestiftelsen Specialist Center   (Denmark)

Author keywords

Bladder cancer; Chemoprevention; Combination therapy; Experimental model; Tobacco carcinogens

Indexed keywords

ACETYLSALICYLIC ACID; CALCITRIOL; CALCIUM; CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER TUMOR; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET; FATALITY; FLUID INTAKE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOBACCO; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANIMALS; ASPIRIN; CALCIUM; CALCIUM, DIETARY; CARCINOGENS; DISEASE MODELS, ANIMAL; MICE; SMOKING; TOBACCO; URINARY BLADDER NEOPLASMS; VITAMIN D;

EID: 84881308286     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357907.2013.820316     Document Type: Article

References (21)

1. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet 2009;374:239-249
2. Maffezzini M, Audisio R, Pavone-Macaluso M, Hall RR. Bladder cancer. Crit Rev Oncol Hematol 1998;27:151-153
3. Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, Lopez-Abente G, Tzonou A, Chang-Claude J, Bolm-Audorff U, Jockel KH, Donato F, Serra C, Wahrendorf J, Hours M, T'Mannetje A, Kogevinas M, Boffetta P. Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies. Int J Cancer 2000;86:289-294
4. Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC. Gender-And smoking-related bladder cancer risk. J Natl Cancer Inst 2001;93: 538-545
5. Verma N, Pink M, Petrat F, Rettenmeier AW, Schmitz-Spanke S. Exposure of primary porcine urothelial cells to benzo(a)pyrene: In vitro uptake, intracellular concentration, and biological response. Arch Toxicol 2012;86:1861-71
6. La Rochelle J, Kamat A,GrossmanHB, Pantuck A. Chemoprevention of bladder cancer. BJU Int 2008;102:1274-1278
7. Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002;94:252-266
8. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW, Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322-1327
9. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: Potential for anticancer therapeutics. Nat Rev Cancer 2007;7:684-700
10. Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt PA, Colditz GA, Folsom AR, Fraser GE, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Miller AB, Pietinen P, Potter JD, Rohan TE, Terry P, Toniolo P,Virtanen MJ,WillettWC, Wolk A,Wu K, Yaun SS, Zeleniuch-Jacquotte A, Hunter DJ. Dairy foods, calcium, and colorectal cancer: A pooled analysis of 10 cohort studies. J Natl Cancer Inst 2004;96:1015-1022
11. Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, Riboli E, Hercberg S, Norat T.Meta-Analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2011;20:1003-1016
12. Hecht SS, Isaacs S, Trushin N. Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-Pyridyl)-1-butanone and benzo[a]pyrene: A potentially useful model for evaluation of chemopreventive agents. Carcinogenesis 1994;15:2721-2725
13. patft.uspto.gov (Internet). Patent no. 7,851,461 and 6,703,380. Accessed on 20 February 2013
14. Shariat SF, Kim JH, Ayala GE, Kho K, Wheeler TM, Lerner SP. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. J Urol 2003;169:938-942
15. Mohammed SI, Bennett PF, Craig BA, Glickman NW, Mutsaers AJ, Snyder PW, Widmer WR, DeGortari AE, Bonney PL, Knapp DW. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Res 2002;62: 356-358
16. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252-261
17. Chu DZ, Hussey MA, Alberts DS, Meyskens FL., Jr., Fenoglio-Preiser CM, Rivkin SE, Mills GM, Giguere JK, Blanke CD, Goodman GE. Colorectal chemoprevention pilot study (SWOG-9041), randomized and placebo controlled: The importance of multiple luminal lesions. Clin Colorectal Cancer 2011;10: 310-316
18. Wang JL, Lin YW, Chen HM, Kong X, Xiong H, Shen N, Hong J, Fang JY. Calcium prevents tumorigenesis in a mouse model of colorectal cancer. PLoS One 2011;6:e22566
19. Hotaling JM, Wright JL, Pocobelli G, Bhatti P, Porter MP,White E. Long-Termuse of supplemental vitamins andminerals does not reduce the risk of urothelial cell carcinoma of the bladder in the vitamins and lifestyle study. J Urol 2011;185:1210-1215
20. Lipkin M. Early development of cancer chemoprevention clinical trials: Studies of dietary calcium as a chemopreventive agent for human subjects. Eur J Cancer Prev 2002;11(Suppl 2): 65-70
21. Lanas A, Sopena F. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications. Gastroenterol Clin North Am 2009;38:333-352